Evidence map›Paper›PMID 38055839›Full record

ArticleBriefings in bioinformatics2023

Using the PharmCAT tool for Pharmacogenetic clinical decision support.

Kevin Tippenhauer, Marwin Philips, Carlo Largiadèr, Murat Sariyar

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kevin TippenhauerBern University of Applied Sciences, Quellgasse 21, 2500 Biel, Switzerland.
Marwin PhilipsBern University of Applied Sciences, Quellgasse 21, 2500 Biel, Switzerland.
Carlo LargiadèrDepartment of Clinical Chemistry at the Bern University Hospital, Bern, Switzerland.
Murat SariyarBern University of Applied Sciences, Quellgasse 21, 2500 Biel, Switzerland.ORCID 0000-0003-3432-2860

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we will provide our insights into the usage of PharmCAT as part of a pharmacogenetic clinical decision support pipeline, which addresses the challenges in mapping clinical dosing guidelines to variants to be extracted from genetic datasets. After a general outline of pharmacogenetics, we describe some features of PharmCAT and how we integrated it into a pharmacogenetic clinical decision support system within a clinical information system. We conclude with promising developments regarding future PharmCAT releases.

Indexed as

Decision Support Systems, ClinicalPharmacogeneticsCDSSclinical information systemCPIC guidelinespharmacogeneticspharmacogenomics

Identifiers

PMID38055839
PMCPMC10699732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.